Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule

The medical technology company announced equity awards for new hires as a material inducement to employment.

Apr. 8, 2026 at 8:05pm

Got story updates? Submit your updates here. ›

A high-end, photorealistic studio still-life photograph featuring a polished, geometric metal medical device or component, such as a dialysis machine part or sensor, elegantly arranged on a clean, monochromatic seamless background with dramatic lighting and sharp shadows, conceptually representing the advanced technology and innovation of Outset Medical's dialysis solutions.Outset Medical's cutting-edge dialysis technology is represented by a sleek, minimalist studio still life that captures the company's commitment to innovation and design.San Jose Today

Outset Medical, Inc., a medical technology company, announced that the Compensation Committee of its Board of Directors approved equity awards under the Company's Inducement Plan as a material inducement to employment for Derick Elliott, the newly appointed Executive Vice President of Commercial, as well as one newly appointed non-executive employee. The equity awards were granted in the form of restricted stock units (RSUs), with 96,000 RSUs granted to Mr. Elliott and 10,380 RSUs granted to the other non-executive employee.

Why it matters

The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4), which requires a public announcement of any equity awards that are not made under a stockholder approved equity plan. This announcement provides transparency around Outset Medical's compensation practices and its efforts to attract and retain key talent to drive the company's growth and innovation in the dialysis technology market.

The details

The RSUs will vest over a period of three years, with 33.33% vesting on the one-year anniversary of each employee's start date and the remaining 66.67% vesting in quarterly installments thereafter, subject to continued service through the applicable vesting dates and subject further to acceleration or forfeiture upon the occurrence of certain events as set forth in each employee's award agreement.

  • Outset Medical announced the equity awards on April 8, 2026.

The players

Outset Medical, Inc.

A medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity.

Derick Elliott

The newly appointed Executive Vice President of Commercial at Outset Medical.

Got photos? Submit your photos here. ›

The takeaway

Outset Medical's announcement of the inducement grants highlights the company's commitment to attracting and retaining top talent as it continues to drive innovation in the dialysis technology market. The equity awards, granted in accordance with Nasdaq listing rules, demonstrate the company's focus on aligning the interests of its key employees with those of its shareholders.